Clinical Trial Update: A Functional MRI Study on Erenumab Treatment Effects in Episodic Migraine Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating functional MRI effects of erenumab treatment in episodic migraine patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine Disorders

Drugs mentioned

• erenumab (erenumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Migraine Disorders | Phase 4 | Status: COMPLETED